Saint Agnes Hospital in Baltimore, Maryland is a full-service teaching hospital located at 900 S. Caton Avenue.

There are 254 beds in Saint Agnes Hospital.

During the past decade, Saint Agnes Hospital conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 47 clinical trials were completed, i.e. on average, 72.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 33 clinical trials were completed. i.e. 165% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Agnes Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Novartis Pharmaceuticals" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored and "Incyte Corporation" with 8 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Agnes Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Saint Agnes Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (5 trials), "Multiple Myeloma" (5 trials) and "Stage IV Lung Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Saint Agnes Hospital" in a lesser frequency.

Most popular intervention types in "Saint Agnes Hospital" are "Drug" (97 trials), "Other" (45 trials), "Biological" (29 trials), "Radiation" (22 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (20 trials), "Placebo" (15 trials), "Paclitaxel" (12 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Saint Agnes Hospital" are 104 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Agnes Hospital". undefined are not yet recruiting, 15 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Saint Agnes Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Agnes Hospital, 2 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".